Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study von Kelsey, C R, Scott, J M, Lane, A, Schwitzer, E, West, M J, Thomas, S, Herndon II, J E, Michalski, M G, Horwitz, M E, Hennig, T, Jones, L W

Volltext

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study von Reardon, D A, Desjardins, A, Vredenburgh, J J, Gururangan, S, Sampson, J H, Sathornsumetee, S, McLendon, R E, Herndon, J E, Marcello, J E, Norfleet, J, Friedman, A H, Bigner, D D, Friedman, H S

Volltext

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients von Reardon, D A, Herndon, J E, Peters, K B, Desjardins, A, Coan, A, Lou, E, Sumrall, A L, Turner, S, Lipp, E S, Sathornsumetee, S, Rich, J N, Sampson, J H, Friedman, A H, Boulton, S T, Bigner, D D, Friedman, H S, Vredenburgh, J J

Volltext

Treatment with imatinib in nsclc is associated with decrease of phosphorylated PDGFR-β and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation von VLAHOVIC, G, RABBANI, Z. N, HERNDON, J. E, DEWHIRST, M. W, VUJASKOVIC, Z

Volltext

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications von KWIATKOWSKI, D. J, HARPOLE, D. H, GODLESKI, J, HERNDON, J. E, SHIEH, D.-B, RICHARDS, W, BLANCO, R, XU, H.-J, STRAUSS, G. M, SUGARBAKER, D. J

Volltext

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902 von Rocha-Lima, C.M., Herndon, J.E., Lee, M.E., Atkins, J.N., Mauer, A., Vokes, E., Green, M.R.

Volltext

Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B von Herndon, James E., Green, Mark R., Chahinian, A. Phillippe, Corson, Joseph M., Suzuki, Yasunosuke, Vogelzang, Nicholas J.

Volltext

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy... von CHOI, N. C, HERNDON, J. E, ROSENMAN, J, CAREY, R. W, CHUNG, C. T, BERNARD, S, LEONE, L, SEAGREN, S, GREEN, M

Volltext

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity von Socinski, M. A., Zhang, C., Herndon, J. E., Dillman, R. O., Clamon, G., Vokes, E., Akerley, W., Crawford, J., Perry, M. C., Seagren, S. L., Green, M. R.

Volltext

A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers von D'Amico, MD, Thomas A., Massey, MD, Marga, Herndon II, PhD, James E., Moore, Mary-Beth, Harpole, David H.

Volltext

Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? von Herndon, James E., Fleishman, Stewart, Kornblith, Alice B., Kosty, Michael, Green, Mark R., Holland, Jimmie

Volltext

Clinical and dosimetric predictors of radiation-induced esophageal toxicity von Maguire, Patrick D, Sibley, Gregory S, Zhou, Su-Min, Jamieson, Timothy A, Light, Kim L, Antoine, Phillip A, Herndon, James E, Anscher, Mitchell S, Marks, Lawrence B

Volltext

Correlation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung Cancer von Patz, Edward F., Rossi, Santiago, Harpole, David H., Herndon, James E., Goodman, Philip C.

Volltext

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors von GRAHAM, M. L, HERNDON, J. E, PALEOLOGUS, N, PENNINGTON, C. N, FRIEDMAN, H. S, CASEY, J. R, CHAFFEE, S, CIOCCI, G. H, KRISCHER, J. P, KURTZBERG, J, LAUGHLIN, M. J, LONGEE, D. C, OLSON, J. F

Volltext

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression von HARPOLE, D. H, HERNDON, J. E, WOLFE, W. G, IGLEHART, J. D, MARKS, J. R

Volltext

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence von Harpole, David H., Herndon, James E., Young, W. Glenn, Wolfe, Walter G., Sabiston, David C.

Volltext

Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083 von PERRY, M. C, HERNDON, J. E, EATON, W. L, GREEN, M. R, B, L. G

Volltext

Using Plasma Transforming Growth Factor Beta-1 During Radiotherapy to Select Patients for Dose Escalation von ANSCHER, Mitchell S, MARKS, Lawrence B, JIRTLE, Randy L, SHAFMAN, Timothy D, CLOUGH, Robert, HONG HUANG, TISCH, Andrea, MUNLEY, Michael, HERNDON, James E, GARST, Jennifer, CRAWFORD, Jeffrey

Volltext

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results von BIGNER, D. D, BROWN, M. T, PEGRAM, C. N, WIKSTRAND, C. J, HERNDON, J. E, VICK, N. A, PALEOLOGOS, N, COKGOR, I, PROVENZALE, J. M, ZALUTSKY, M. R, FRIEDMAN, A. H, COLEMAN, R. E, AKABANI, G, FRIEDMAN, H. S, THORSTAD, W. L, MCLENDON, R. E, BIGNER, S. H, ZHAO, X.-G

Volltext

Social support as a buffer to the psychological impact of stressful life events in women with breast cancer von Kornblith, Alice B., Herndon, James E., Zuckerman, Enid, Viscoli, Catherine M., Horwitz, Ralph I., Cooper, M. Robert, Harris, Lyndsay, Tkaczuk, Katherine H., Perry, Michael C., Budman, Daniel, Norton, Larry, Holland, Jimmie C.

Volltext